Noah S. Kalman, MD, MBA, discusses the evolving role of molecular and genetic testing in thyroid cancer management.

Yourgene Health (part of the Novacyt group of companies), a leading international molecular diagnostics group, today announced the launch of IONA® Care+, a fully comprehensive non-invasive prenatal ...

LAHORE: The University of Health Sciences (UHS) Lahore is all set to inaugurate its state-of-the-art diagnostic laboratory on ...

The biochemist introduced the first heel-prick tests for newborn babies in Spain, protecting infants from life-changing ...

Yourgene was acquired by Novacyt in September 2023, in a £16.7m deal.

Natera (NTRA) commented on recent updates by the NCCN on circulating tumor DNA molecular residual disease testing in the Clinical Practice ...

According to the World Health Organization (WHO), hundreds of millions of new cases of bacterial sexually transmitted ...

The Decipher Bladder Genomic Subtyping Classifier found that patients with luminal tumors may have less aggressive disease.

A new study has discovered in mouse models that genes associated with repairing mismatched DNA are critical in eliciting damages to neurons that are most vulnerable in Huntington's disease and ...

Laboratories “announced that the company has entered into a binding offer to purchase all equity interests in Stilla ...

Introduction Blood cancer diagnostics refers to the process of detecting and identifying cancers that affect the blood, bone marrow, and lympha ...

Last year, at the Open Day of the CSIR-Centre for Cellular and Molecular Biology (CCMB), a biology research institute in ...